We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Ezra Cohen MD

Ezra Cohen MD

Associate Professor of Medicine, Pritzker School of Medicine, and Co-Director, Head and Neck Cancer Program, University of Chicago

Dr. Ezra Cohen is an associate professor of medicine at the Pritzker School of Medicine and co-director of the Head and Neck Cancer Program at the University of Chicago. His primary focus has been in the area of head and neck cancers, including both patient-oriented and laboratory research, with access to tissues, patient materials, and novel agents. This unique perspective permits an appreciation of the critical research questions that need to be addressed along with the ability to apply basic science discoveries to improve outcomes. He has been involved in all phases and aspects of clinical trials in oncology and chemoprevention, focusing on head and neck cancer, for more than a decade. He has published extensively in this field, especially in clinical strategies and outcomes.

Dr. Cohen is currently Editor-in-Chief of Oral Oncology, the highest impact specialty journal in head and neck cancer. He is a member of the National Cancer Institute’s Head and Neck Cancer Steering Committee, the CNS/head and neck committee of the American College of Radiology Imaging Network (ACRIN), and the American College of Surgeons Oncology Group (ACOSOG) Head and Neck Cancer Task Force. Additionally, he sits on grant review panels for the American Association for Cancer Research, American Society of Clinical Oncology, and the Ontario Institute for Cancer Research.